Sulforaphane ( DrugBank: Sulforaphane )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	1
205	Fragile X syndrome related disease	1

6. Parkinson disease

---

Clinical trials : 2,307 /  Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05084365 (ClinicalTrials.gov)	October 10, 2021	7/10/2021	A 6-month Study to Evaluate Sulforaphane Effects in PD Patients	A 6-month Study to Evaluate Sulforaphane Effects in Treatment of Cognition Impairment of PD Patients	Parkinson Disease	Drug: Sulforaphane;Drug: Placebo	Central South University	NULL	Not yet recruiting	40 Years	75 Years	All	100	Phase 2	NULL

205. Fragile X syndrome related disease

---

Clinical trials : 5 /  Drugs : 7 - (DrugBank : 5) / Drug target genes : 22 - Drug target pathways : 25

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05233579 (ClinicalTrials.gov)	June 25, 2021	20/10/2021	Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS	Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers	Fragile X Associated Tremor/Ataxia Syndrome (Fxtas) (Diagnosis)	Dietary Supplement: Sulforaphane	University of California, Davis	NULL	Recruiting	50 Years	85 Years	All	15	N/A	United States